These functions make GLP-1 a central player in blood sugar control, appetite regulation, and even cardiovascular health, with benefits like improved endothelial function
There are several mechanisms by which these drugs result in weight loss, with MOST of the effect being related to hunger and satiety
Semaglutide can sometimes cause nausea, vomiting, and stomach discomfort
The biphasic dose-response The finding that 50 mg/mL outperformed 100 mg/mL mirrors what was observed in the laboratory copper peptides show optimal activity within a specific concentration window
The oral GLP-1 component is becoming commercially important as it allows combining the promise of efficacy generated by injectable GLP-1 drugs with the convenience of the oral route of administration
Significance of FDA Approval Sally Seymour, M.D., director of the Division of Pulmonology, Allergy and Critical Care at the FDA, underscored the significance of this landmark decision, noting that it introduces the first drug treatment option for certain patients with OSA